Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Prof. Hagit Cohen | Medicine and Health Sciences | Research Excellence Award

Prof. Hagit Cohen | Medicine and Health Sciences | Head of Anxiety at Ben Gurion University | Israel

Prof. Hagit Cohen is a distinguished neuroscientist and psychiatrist internationally recognized for her pioneering contributions to stress biology, psychobiology, and translational research in anxiety and post-traumatic stress disorder. Prof. Hagit Cohen completed her undergraduate training in life sciences and her master’s and doctoral education in biomedical engineering and life sciences at Ben-Gurion University of the Negev, where her doctoral research focused on neurophysiological and spectral analysis approaches to mental fatigue and stress-related mechanisms. She later advanced her expertise through postdoctoral training in clinical biochemistry and pharmacology, strengthening her translational orientation between basic neuroscience and clinical psychiatry. Prof. Hagit Cohen currently serves as a senior academic leader in psychiatry and neuroscience, holding prestigious chaired and professorial positions while directing a nationally influential Anxiety and Stress Research Unit that integrates clinical, behavioral, neuroendocrine, and molecular approaches. Prof. Hagit Cohen is highly skilled in translational animal models, psychopharmacology, neuroendocrine profiling, behavioral neuroscience, biomarker discovery, and interdisciplinary clinical research design. She has authored 212 documents, received 13,692 citations, and holds an h-index of 65, reflecting the sustained international impact of her scholarship.

Citation Metrics (Scopus)

25000

20000

15000

10000

5000

0

Citations
13,692

Documents
212

h-index
65

🟦 Citations       🟥 Documents    🟩 h-index


View Scopus Profile
       View ORCID Profile     View Google Scholar Profile

Featured Publications

Exploring the Anxiolytic Potential of NPY by a Dipeptidyl Peptidase-IV Inhibitor in an Animal Model of PTSD
– International Journal of Neuropsychopharmacology, 2024 (7 Citations)
Loss of the Zinc Receptor ZnR/GPR39 in Mice Enhances Anxiety-Related Behavior and Motor Deficits, and Modulates KCC2 Expression in the Amygdala
– Behavioral and Brain Functions, 2024 (1 Citation)
ZNF142 Mutation Causes Sex-Dependent Neurologic Disorder
– Journal of Medical Genetics, 2024 (4 Citations)
Neuro-Psychiatric Symptoms in Directly and Indirectly Blast-Exposed Civilian Survivors of Urban Missile Attacks
– BMC Psychiatry, 2023 (6 Citations)
Sounds of Danger and Post-Traumatic Stress Responses in Wild Rodents: Ecological Validity of a Translational Model of PTSD
– Molecular Psychiatry, 2023 (6 Citations)
Hydrocortisone in the Emergency Department: A Prospective, Double-Blind, Randomized Controlled PTSD Study
– CNS Spectrums, 2023 (8 Citations)
Promoter Methylation of the Glucocorticoid Receptor Following Trauma and Its Association With PTSD Development
– World Journal of Biological Psychiatry, 2023 (5 Citations)

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.

Publication top notes

Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus

Prevalence of avian respiratory viruses in broiler flocks in Egypt

Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens

Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United States

Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns

Molecular characterization of Newcastle disease virus (genotype VII) from broiler chickens in Egypt

Co-infections, genetic, and antigenic relatedness of avian influenza H5N8 and H5N1 viruses in domestic and wild birds in Egypt

Protective efficacy of different live attenuated infectious bronchitis virus vaccination regimes against challenge with IBV variant-2 circulating in the Middle East

The emergence, evolution and spread of infectious bronchitis virus genotype GI-23